跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,688 条关于
“Atypical antipsychotics”
全部
4,688
临床试验
4,264
药物
59
机构
0
资讯
365
去年
Atypical Antipsychotics in Dementia: Balancing Benefits and Risks in BPSD Management
去年
Vanda Pharmaceuticals Submits NDA for Novel Antipsychotic Bysanti to Treat Bipolar I Disorder and Schizophrenia
4个月前
CAPLYTA Shows Superior Efficacy Among Adjunctive Depression Treatments in First Network Meta-Analysis
去年
FDA Approves Iloperidone (Fanapt®) for Acute Treatment of Bipolar I Disorder
去年
Bristol Myers Squibb Presents New COBENFY Data for Schizophrenia Treatment at Psych Congress
5个月前
Bristol Myers Squibb's Cobenfy Shows Stable Transition Profile in Phase 4 Schizophrenia Trial
去年
IGC Pharma Receives Patent Allowance for THC Microdose Treatment Targeting Tourette's Syndrome and Speech Disorders
去年
Schizophrenia Market Set for Strong Growth, Driven by Novel Therapies
9个月前
Newron Initiates ENIGMA-TRS 2 Phase III Trial for Treatment-Resistant Schizophrenia in US
上个月
Antipsychotic ADRs Affect 61.7% of Ugandan Psychiatric Outpatients, Study Finds
第 1 页,共 37 页
上一页
下一页